Neutralizing Antibodies

Neutralizing antibodies bind to their target an impair the biological activity of the target, rather than simply flagging the target for host leukocytes. This is an approach that is being used in vaccine development. Find the latest research on neutralizing antibodies here.

August 11, 2020

Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Nina BabelTimm H Westhoff
August 6, 2020

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody

Matthijs MeijersMichael Laessig
August 10, 2020

NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function

Experimental & Molecular Medicine
Ji-Hee KimYoung-Myeong Kim
August 10, 2020

Evidence of exposure to zoonotic flaviviruses in zoo mammals in Spain and their potential role as sentinel species

Veterinary Microbiology
J Caballero-GómezI García-Bocanegra
August 11, 2020
Open Access

Comparison of three different ELISAs for the detection of recombinant, native and plasma IL-17A

Mohamad Bachar IsmailHélène Valentin
August 8, 2020
Open Access

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis

JACC. Basic to Translational Science
Nicolas PerrotBenoit J Arsenault
August 7, 2020
Comment / Editorial

Emapalumab in Primary Hemophagocytic Lymphohistiocytosis

The New England Journal of Medicine
Jan-Inge HenterElisabet Bergsten
August 8, 2020

Zika virus-induced neuro-ocular pathology in immunocompetent mice correlates with anti-ganglioside autoantibodies

Human Vaccines & Immunotherapeutics
Jacob T BeaverIoanna Skountzou
August 10, 2020

Advances in simian--human immunodeficiency viruses for nonhuman primate studies of HIV prevention and cure

Current Opinion in HIV and AIDS
Anya M Bauer, Katharine J Bar
August 11, 2020

Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus

Gustavo H DayanCarlos A DiazGranados
August 7, 2020

Interleukin 35 Regulatory B Cells

Journal of Molecular Biology
Jin Kyeong Choi, Charles E Egwuagu
August 10, 2020

Gene Therapy for Hemophilia A: Where We Stand

Current Gene Therapy
Miaojin ZhouDesheng Liang

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2020 Meta ULC. All rights reserved